Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.
about
COPD and stroke: are systemic inflammation and oxidative stress the missing links?Optimizing management of chronic obstructive pulmonary disease in the upcoming decade.Viral Etiology of Chronic Obstructive Pulmonary Disease Exacerbations during the A/H1N1pdm09 Pandemic and Postpandemic PeriodCough and its importance in COPDPlasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.Sputum myeloperoxidase in chronic obstructive pulmonary disease.Qualitative analysis of high-resolution CT scans in severe asthmaNovel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.Management of an acute exacerbation of copd: are we ignoring the evidence?Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods.Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary diseaseIncreased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitisPatients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammationC-reactive protein levels in stable COPD patients: a case-control studyStrategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.Research opportunities in the management of acute exacerbations of chronic obstructive pulmonary disease.Acute mechanical forces cause deterioration in lung structure and function in elastase-induced emphysema.Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?COPD exacerbations . 2: aetiologyDynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study.Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex.Innate host defense functions of secretory leucoprotease inhibitor.Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studiesAntioxidant therapeutic advances in COPD.Recent advances in pre-clinical mouse models of COPD.Efficacy of tiotropium in the prevention of exacerbations of COPD.Regulation and activity of secretory leukoprotease inhibitor (SLPI) is altered in smokers.Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease.Is there a role for antiinflammatory treatment in COPD?Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.Pharmacological antioxidant strategies as therapeutic interventions for COPD.Pulmonary biomarkers in COPD exacerbations: a systematic review.Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis.The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients.The Factors Influencing Relapse in Patients Presenting to the Emergency Department with COPD Exacerbation.Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.
P2860
Q26746530-3BD398A3-E145-4779-BE67-81874B092FCEQ27693341-77A9FABD-5D7C-498C-BAA2-8878AD5B04D6Q30375530-F568D940-D5DC-49DD-A6F1-883E0C35E79EQ30488037-A2E18187-B5BC-4E66-9C63-9BD34C5CFC99Q33270742-5316DAC8-4090-43FF-BF3E-6463F48AC031Q33592946-AAD998CE-892B-483D-A80E-38D8D417BB5AQ33632072-2BE4F444-D1F0-4747-B1A5-275285CC9B81Q34684239-77262A15-A224-4EC8-9EC5-2E2EDE2200CBQ34938599-3D72843B-A0E6-475C-B3FD-A2C60F824D0EQ34995861-3060D6BF-A6FA-4D2A-9623-D635066FF8C9Q35038218-B34C797C-4CA0-48F9-BDC8-AF4D1A1A365EQ35535840-80209697-2AA7-4A53-B49F-412A2C8C0378Q35536126-72CC35CD-ED38-41CE-B440-28C2A1E9BEDAQ35594061-8E639236-D2CB-4672-9623-FF71DF6AB456Q36029240-EDD64C2E-FB4D-4A5F-90AB-462DB00C3E7EQ36036223-9237A6A1-B4E3-4C5B-9C16-C555FBEE19E2Q36114167-D8AA5F7F-26D0-4E3F-B174-CEA24D516D69Q36218050-6537E283-2FC9-4C6D-90E0-7D74AAF6407EQ36312351-1E0D4F94-D318-4E2C-A19F-01B25F95DE3EQ36376519-AF55B6C6-977C-44E6-AF07-18B118868176Q36414253-A115A5F0-3661-4A58-BEAB-1D7E39657A06Q36732429-7876907F-AB62-4AF9-A74C-448A0E3640FCQ36862444-81FF57D1-7705-4330-A0DA-3E0796A0F842Q37030651-6FE8EE33-1CA4-4370-8558-26605CB3452CQ37115894-AA026371-2B23-446F-9710-830106FBF93FQ37199668-5CB09736-1BDE-4475-B98C-6F6D79FCEB42Q37348279-0EB3999E-978D-454A-8C67-CB8F8682F296Q37426720-47AD7A4F-6210-4FB4-8958-B6D8ADD6DED0Q37555782-363BBCE0-B749-475B-8218-B20F6143CB85Q37576058-AF39184D-8549-49CE-9655-AE26ABC0E5ECQ37619683-857D7345-CBB1-475A-AD00-A9DC6FC5C592Q37622935-C6766A42-E17B-469E-B78C-ED23507699E3Q37731798-07EC44B2-3CCE-46CA-ADCC-5CF0E34EB644Q37958591-8E717977-2129-4349-93EC-E00326592E91Q38154291-3AFC443A-F949-4178-AE47-EC98507F6415Q38240136-2444599D-247A-4406-BD4C-D154C3C06062Q38646619-47D9BAAB-C928-4CC9-B4AB-4AA3A0768CB2Q39426025-F6142B64-1D98-4991-87B5-6E0E9DD6855EQ39660760-286B469B-3275-4A4E-A149-814701F901ACQ40179319-AEFAEC98-B8B7-41CF-BF8B-E420A5139ED6
P2860
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Relationship between airway in ...... nts with smoking related COPD.
@ast
Relationship between airway in ...... nts with smoking related COPD.
@en
type
label
Relationship between airway in ...... nts with smoking related COPD.
@ast
Relationship between airway in ...... nts with smoking related COPD.
@en
prefLabel
Relationship between airway in ...... nts with smoking related COPD.
@ast
Relationship between airway in ...... nts with smoking related COPD.
@en
P2093
P2860
P356
P1433
P1476
Relationship between airway in ...... nts with smoking related COPD.
@en
P2093
P2860
P356
10.1136/THORAX.56.1.36
P407
P577
2001-01-01T00:00:00Z